{"id":"W4400272952","doi":"10.1200/jco.2024.42.16_suppl.4566","title":"Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Medicine; Metastatic Urothelial Carcinoma; Avelumab; Internal medicine; Clinical endpoint; Randomization; Oncology; Bladder cancer; Urology; Surgery; Randomized controlled trial; Urothelial carcinoma; Immunotherapy; Nivolumab; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001203915,0.0003903489,0.001020506,0.0002281231,0.0002613899,0.0005996436,0.000409921,0.0005138563,0.001710613],"category_scores_gemma":[0.0006723925,0.0002434458,0.001309135,0.0002882952,0.0005290796,0.0005317889,0.0004070425,0.001385822,0.0002435171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006230657,"about_ca_system_score_gemma":0.000712221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005949592,"about_ca_topic_score_gemma":0.001609572,"domain_scores_codex":[0.999718,0.0001335309,0.00001616637,0.00004698443,0.0000273925,0.00005784102],"domain_scores_gemma":[0.9993936,0.000106648,0.0001680942,0.0000395214,0.00002254197,0.0002696428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8140012,0.02059404,0.05188479,0.0009769303,0.002233428,0.0002099267,0.0002249746,0.002072737,0.0192031,0.0001874953,0.001836995,0.08657439],"study_design_scores_gemma":[0.1722066,0.6605083,0.1538023,0.0001253352,0.002639472,0.0005279655,0.0001208731,0.002275334,0.004418142,0.0002944203,0.003039601,0.00004170336],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977747,0.001175003,0.0001123386,0.00007352968,0.00002150898,0.0001732111,0.0002731292,0.00001032719,0.0003862478],"genre_scores_gemma":[0.9977509,0.0005719181,0.0002205303,0.0001647412,0.000046241,0.0002169662,0.0005976516,0.000003442475,0.0004274159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001710613,"threshold_uncertainty_score":0.006366968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06025855335485555,"score_gpt":0.402080230916988,"score_spread":0.3418216775621324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}